
    
      The patients who were SSRI-resistant will be randomized to ACT, aripiprazole, or SMT.
      Independent evaluators, blind to treatment,will evaluate patients during the study.The
      Yale-Brown Obsessive Compulsive Scale (YBOCS)will be used to measure OCD severity.
    
  